Login / Signup

Plasma therapy: a passive resistance against the deadliest.

Anita HansdaDebarati BiswasAishwarya BhattaNishant ChakravortyGayatri Mukherjee
Published in: Human vaccines & immunotherapeutics (2021)
Convalescent plasma therapy provides a useful therapeutic tool to treat infectious diseases, especially where no specific therapeutic strategies have been identified. The ongoing pandemic puts back the spotlight on this age-old method as a viable treatment option. In this review, we discuss the usage of this therapy in different diseases including COVID-19, and the possible mechanisms of action. The current review also discusses the progress of therapeutic applications of blood-derivatives, from the simple transfer of immunized animal sera, to the more target-specific intravenous administration of human immunoglobulins from a pool of convalescent individuals, in both infectious and non-infectious diseases of various etiologies.
Keyphrases
  • infectious diseases
  • coronavirus disease
  • sars cov
  • endothelial cells
  • high dose
  • stem cells
  • low dose
  • induced pluripotent stem cells
  • pluripotent stem cells
  • replacement therapy